ImmunoGen, Inc.

Historical 13F Holders

Symbol
IMGN
CUSIP
45253H101
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 1 1.00 $269.00
2024 Q4 1 1.00 $269.00
2024 Q3 1 1.00 $269.00
2024 Q2 1 1.00 $31.00
2024 Q1 3 893 $27.8 k
2023 Q4 381 261 M $7.75 B
2023 Q3 305 247 M $3.92 B
2023 Q2 302 226 M $4.26 B
2023 Q1 211 210 M $807 M
2022 Q4 219 222 M $1.11 B
2022 Q3 235 199 M $953 M
2022 Q2 228 196 M $882 M
2022 Q1 238 195 M $925 M
2021 Q4 256 191 M $1.41 B
2021 Q3 233 177 M $1.00 B
2021 Q2 231 181 M $1.19 B
2021 Q1 229 183 M $1.48 B
2020 Q4 226 174 M $1.12 B
2020 Q3 196 142 M $512 M
2020 Q2 200 139 M $641 M
2020 Q1 197 137 M $469 M
2019 Q4 205 114 M $580 M
2019 Q3 202 104 M $252 M
2019 Q2 212 104 M $225 M
2019 Q1 245 118 M $320 M
2018 Q4 219 125 M $597 M
2018 Q3 231 130 M $1.23 B
2018 Q2 216 126 M $1.23 B
2018 Q1 222 106 M $1.11 B
2017 Q4 213 104 M $666 M
2017 Q3 195 90.3 M $691 M
2017 Q2 172 76.2 M $542 M
2017 Q1 145 68.8 M $266 M
2016 Q4 166 68.3 M $139 M
2016 Q3 168 75.4 M $202 M
2016 Q2 172 82.5 M $254 M
2016 Q1 154 77.0 M $656 M
2015 Q4 162 79.2 M $1.07 B
2015 Q3 160 77.9 M $760 M
2015 Q2 152 78.9 M $1.13 B
2015 Q1 154 74.3 M $666 M
2014 Q4 147 70.8 M $433 M
2014 Q3 149 75.1 M $796 M
2014 Q2 149 75.3 M $892 M
2014 Q1 154 76.4 M $1.14 B